Form 4: Core Scientific Director Becker Sells Common Stock and Warrants
SEC Form 4
Director Todd A. Becker of Core Scientific, Inc. executed multiple sales of common stock and warrants on March 3rd and 4th, 2025.
Summary
- Todd A. Becker, a director at Core Scientific, Inc., reported the sale of common stock and warrants.
- On March 3, 2025, Becker sold 134,250 shares of common stock at a weighted average price of $10.7502, with prices ranging from $10.50 to $10.90.
- Also on March 3, 2025, Becker sold 10,763 Tranche 1 Warrants at a weighted average price of $5.5693, with prices ranging from $5.56 to $5.58.
- Additionally, on March 3, 2025, 3,900 Tranche 2 Warrants were sold at a weighted average price of $10.8631, with prices ranging from $10.75 to $10.98.
- On March 4, 2025, Becker sold 5,069 Tranche 2 Warrants at a weighted average price of $9.8939, with prices ranging from $9.7867 to $9.955.
- Following these transactions, Becker directly owns 195,687 shares of common stock and 5,069 Tranche 2 Warrants.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports transactions. The sales could be for various personal reasons and don't necessarily reflect a negative view of the company.
Industry Context
This filing reflects insider trading activity, which is a common occurrence in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's future prospects.
Stakeholder Impact
- Shareholders may interpret the insider selling activity as a lack of confidence in the company's future performance, potentially leading to a decrease in stock price.
- The impact on employees, customers, suppliers, and creditors is likely minimal unless the insider selling signals a broader issue within the company.
Key Dates
| Date | Description |
|---|---|
| 01/23/2024 | Date Tranche 1 Warrants became exercisable |
| 07/11/2024 | The Tranche 2 Warrants became exercisable at the option of the registered holders |
| 01/23/2027 | Expiration date of Tranche 1 Warrants |
| 01/23/2029 | Expiration date of Tranche 2 Warrants |
| 03/03/2025 | Date of common stock and warrant sales |
| 03/04/2025 | Date of warrant sales |
| 03/05/2025 | Date of signature on the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.